Patient-reported outcomes in breast cancer FDA drug labels and review documents
Abstract Background Patient-reported outcomes (PROs) can provide valuable information about drug benefit-risk tradeoffs from the patient perspective and are particularly important to patients with breast cancer due to its symptoms and adverse events from breast cancer treatments. The United States F...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
SpringerOpen,
2021-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|